Real-World Effectiveness of PLD in Platinum- Sensitive Recurrent Ovarian Cancer
Condition: Ovarian Carcinoma Interventions: Drug: pegylated liposomal doxorubicin (PLD) + carboplatin (CD); Drug: carboplatin + paclitaxel (CP) Sponsors: Konkuk University Medical Center; Seoul National University Hospital; National Cancer Center, Korea; Asan Medical Center; The Catholic University of Korea; Samsung Medical Center; Chung-Ang University Hosptial, Chung-Ang University College of Medicine; Ajou University; Severance Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials